J.P. Bercu
Advertisement
J.P. Bercu is senior director in nonclinical safety and pathobiology, Gilead Sciences.
Articles by J.P. Bercu
Advertisement
Latest Updated Articles
Managing the Risk of Nitrosamine ImpuritiesPublished: March 16th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
Genetic Medicines Project Gets Funding from UKRI Innovate UK and Canadian NRC IRAP
4
Navigating Financial and Opportunity Risks in Accelerated Drug Launches
5